Myeloma Patients Treated at High-volume Facilities Have Lower Risk of Death, Study Finds
Multiple myeloma (MM) patients treated at facilities that handle…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
First Myeloma Patient Joins Trial of Therapy for Cancers That Failed to Respond to Treatment
The first multiple myeloma patient has enrolled in a…
Artist Will Donate Part of Proceeds from Hollyweed T-shirt Sales to Myeloma
A man who calls himself a Hollyweed artist…
Patients with Indolent Myeloma Don’t Benefit from ICAM1 Inhibitor, Trial Results Show
Patients with smoldering multiple myeloma (SMM), an asymptomatic form…
Phase 1 Trial to Assess Safety of Radioactive Anti-CD33 Antibody in Advanced Myeloma
A Phase 1 trial will soon be assessing Actimab-M, an anti-CD33…
Patients Value Obamacare More Than General Public and Oppose Its Repeal, Survey Says
People with chronic diseases value the Affordable Care Act…
